Perttu Arkkila

6.5k total citations
94 papers, 3.2k citations indexed

About

Perttu Arkkila is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Perttu Arkkila has authored 94 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 29 papers in Surgery and 23 papers in Genetics. Recurrent topics in Perttu Arkkila's work include Microscopic Colitis (31 papers), Inflammatory Bowel Disease (22 papers) and Clostridium difficile and Clostridium perfringens research (18 papers). Perttu Arkkila is often cited by papers focused on Microscopic Colitis (31 papers), Inflammatory Bowel Disease (22 papers) and Clostridium difficile and Clostridium perfringens research (18 papers). Perttu Arkkila collaborates with scholars based in Finland, France and United States. Perttu Arkkila's co-authors include Jorma Viikari, Martti Färkkilâ, Ilkka Kantola, Jean–François Gautier, Ulla Turunen, Tapani Rönnemaa, Hannele Yki‐Järvinen, Anders Hamsten, Reetta Satokari and Jukka Westerbacka and has published in prestigious journals such as Gastroenterology, Diabetes and Clinical Infectious Diseases.

In The Last Decade

Perttu Arkkila

85 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perttu Arkkila Finland 31 1.5k 1.0k 717 698 673 94 3.2k
Eran Israeli Israel 32 1.2k 0.8× 724 0.7× 529 0.7× 191 0.3× 1.0k 1.6× 96 3.5k
Jana G. Hashash United States 31 1.4k 0.9× 1.1k 1.1× 515 0.7× 231 0.3× 1.6k 2.4× 249 3.7k
William R. Treem United States 36 1.1k 0.7× 1.3k 1.2× 1.0k 1.5× 154 0.2× 1.2k 1.8× 140 4.5k
Rodolphe Anty France 36 3.0k 2.0× 1.1k 1.1× 857 1.2× 165 0.2× 353 0.5× 112 5.1k
Davide Giuseppe Ribaldone Italy 29 1.1k 0.7× 788 0.8× 488 0.7× 163 0.2× 914 1.4× 182 2.6k
Gabriele Riegler Italy 29 1.4k 0.9× 1.3k 1.2× 621 0.9× 175 0.3× 1.6k 2.4× 84 3.7k
Maria Grazia Clemente Italy 22 1.1k 0.7× 748 0.7× 463 0.6× 109 0.2× 500 0.7× 63 2.7k
Valentina Giorgio Italy 27 992 0.6× 869 0.8× 877 1.2× 144 0.2× 213 0.3× 117 2.9k
Pedro Zapater Spain 34 1.5k 1.0× 808 0.8× 912 1.3× 314 0.4× 264 0.4× 169 3.7k
Giovanni Marasco Italy 30 1.2k 0.8× 1.0k 1.0× 774 1.1× 209 0.3× 204 0.3× 151 3.4k

Countries citing papers authored by Perttu Arkkila

Since Specialization
Citations

This map shows the geographic impact of Perttu Arkkila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perttu Arkkila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perttu Arkkila more than expected).

Fields of papers citing papers by Perttu Arkkila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perttu Arkkila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perttu Arkkila. The network helps show where Perttu Arkkila may publish in the future.

Co-authorship network of co-authors of Perttu Arkkila

This figure shows the co-authorship network connecting the top 25 collaborators of Perttu Arkkila. A scholar is included among the top collaborators of Perttu Arkkila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perttu Arkkila. Perttu Arkkila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Löyttyniemi, Eliisa, et al.. (2025). Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 70(4). 1457–1466.
2.
Meriranta, Leo, et al.. (2025). Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection. Therapeutic Advances in Gastroenterology. 18. 1128501268–1128501268.
3.
Peyrin‐Biroulet, Laurent, Perttu Arkkila, Alessandro Armuzzi, et al.. (2024). Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials. BMC Gastroenterology. 24(1). 121–121. 3 indexed citations
4.
Boyd, Sonja, Johanna Louhimo, Soili Kytölä, et al.. (2024). Next-generation sequencing improves diagnostic accuracy of imaging and carcinoembryonic antigen alone for pancreatic cystic neoplasms. Pancreatology. 24(8). 1322–1331. 3 indexed citations
5.
Nyyssönen, Mari, et al.. (2024). Multidisciplinary behavioral therapy reduces rumination. Neurogastroenterology & Motility. 36(12). e14919–e14919. 1 indexed citations
6.
Jalanka, Jonna, Perttu Lahtinen, Alise J. Ponsero, et al.. (2024). Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients. npj Biofilms and Microbiomes. 10(1). 73–73. 8 indexed citations
7.
Peyrin‐Biroulet, Laurent, Peter Bossuyt, Dominik Bettenworth, et al.. (2024). Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive Diseases and Sciences. 69(5). 1808–1825. 7 indexed citations
8.
Aho, Inka, Olli Tynninen, Anu Suomalainen, et al.. (2024). Effect of 2 Forms of Tenofovir on Duodenal Enterocytes—A Hypothesis for Different Effect of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide on Body Weight and Plasma Lipids. Clinical Infectious Diseases. 80(2). 381–388. 2 indexed citations
9.
10.
Roine, Risto P., et al.. (2021). Behavioral therapy is superior to follow‐up without intervention in patients with supragastric belching—A randomized study. Neurogastroenterology & Motility. 34(2). e14171–e14171. 8 indexed citations
11.
Koskensalo, Selja, et al.. (2021). Preoperative intravenous iron treatment reduces postoperative complications and postoperative anemia in preoperatively anemic patients with colon carcinoma. International Journal of Colorectal Disease. 37(2). 449–455. 7 indexed citations
12.
Jalanka, Jonna, et al.. (2017). The long‐term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection. Alimentary Pharmacology & Therapeutics. 47(3). 371–379. 46 indexed citations
13.
Yki‐Järvinen, Hannele & Perttu Arkkila. (2015). Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 1 indexed citations
14.
Molander, Pauliina, Martti Färkkilâ, Ari Ristimäki, et al.. (2014). Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?. Journal of Crohn s and Colitis. 9(1). 33–40. 83 indexed citations
15.
Mattila, Elina, Perttu Arkkila, Petri S. Mattila, et al.. (2013). Extraintestinal Clostridium difficile Infections. Clinical Infectious Diseases. 57(6). e148–e153. 62 indexed citations
16.
Haapamäki, Johanna, Risto P. Roine, Ulla Turunen, Martti Färkkilâ, & Perttu Arkkila. (2010). Kroonista tulehduksellista suolistosairautta sairastavien elämänlaatu ja hoitokäytännöt. 65(7). 599–604. 1 indexed citations
17.
Nieminen, Urpo, Perttu Arkkila, Päivi Kärkkäinen, & Martti Färkkilâ. (2009). Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C. Liver International. 29(2). 153–158. 9 indexed citations
18.
Greco, Dario, Anna Kotronen, Jukka Westerbacka, et al.. (2008). Gene expression in human NAFLD. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(5). G1281–G1287. 336 indexed citations
19.
Kokkola, Arto, et al.. (2008). Does the eradication ofHelicobacter pyloridelay the diagnosis of gastric cancer?. Scandinavian Journal of Gastroenterology. 43(12). 1456–1460. 6 indexed citations
20.
Arkkila, Perttu, Ilkka Kantola, & Jorma Viikari. (1997). Dupuytren's disease: association with chronic diabetic complications.. PubMed. 24(1). 153–9. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eran Israeli Breakdown of academic impact, for papers by Jana G. Hashash Breakdown of academic impact, for papers by William R. Treem Breakdown of academic impact, for papers by Rodolphe Anty Breakdown of academic impact, for papers by Davide Giuseppe Ribaldone Breakdown of academic impact, for papers by Gabriele Riegler Breakdown of academic impact, for papers by Maria Grazia Clemente Breakdown of academic impact, for papers by Valentina Giorgio Breakdown of academic impact, for papers by Pedro Zapater Breakdown of academic impact, for papers by Giovanni Marasco
Rankless by CCL
2026